Literature DB >> 6257531

Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine.

W J Kinnier, D M Chuang, E Costa.   

Abstract

In rats receiving repeated injections of imipramine, there is a reduction in the number of high affinity binding sites for [3H]imipramine and [3H]dihydroalprenolol present in crude synaptic membrane preparations from various brain structures. The location of the sites that become subsensitive to the two ligands did not coincide; the binding sites to [3H]imipramine became subsensitive in the hippocampus but not in cortex or cerebellum. In contrast the binding sites to [3H]dihydroalprenolol became subsensitive in cortex and cerebellum but not in hippocampus. It can be suggested that in rats repeatedly treated with imipramine the down regulation of beta-adrenergic receptors may not coincide with the down regulation of the high affinity binding sites for imipramine. Such a dissociation is supported further by experiments with rats treated with iprinidol.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6257531     DOI: 10.1016/0014-2999(80)90510-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.

Authors:  M F Poirier; C Benkelfat; H Loo; D Sechter; E Zarifian; A M Galzin; S Z Langer
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  Differential coupling of GABA-A and GABA-B receptors to the noradrenergic system.

Authors:  P D Suzdak; G Gianutsos
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  Unaltered 5-HT- and desipramine-sensitive [3H]imipramine binding and [3H]5-HT uptake in rat brain after chronic imipramine and norzimeldine treatment.

Authors:  J Marcusson; I T Bäckström; S B Ross
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Molecular mechanisms in the action of imipramine.

Authors:  E Costa; D M Chuang; M L Barbaccia; O Gandolfi
Journal:  Experientia       Date:  1983-08-15

6.  3H-Imipramine binding sites in the rat brain. Selective localization on serotoninergic neurones.

Authors:  G Gross; M Göthert; H P Ender; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

7.  Inhibition of presynaptic alpha-2-adrenoceptor and opioid receptor agonist responses in the rat vas deferens by chronic imipramine treatment.

Authors:  R A Keith; A I Salama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

8.  3H-imipramine and 3H-cyano-imipramine binding in rat brain tissue: effect of long-term antidepressant administration.

Authors:  C Gentsch; M Lichtsteiner; H Feer
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

9.  Neuroleptics and beta-carbolines displace (3H)Imipramine from its binding sites in human and rat tissues.

Authors:  H Rommelspacher; S Strauss
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

10.  Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.

Authors:  M L Barbaccia; O Gandolfi; D M Chuang; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.